These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26033450)

  • 1. Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.
    Thang ND; Yajima I; Kumasaka MY; Iida M; Suzuki T; Kato M
    Oncotarget; 2015 Jun; 6(16):14290-9. PubMed ID: 26033450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis.
    Chen L; Niu W; Zang H; Qiu Y
    Biochem Genet; 2024 Apr; 62(2):814-830. PubMed ID: 37460862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
    Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
    Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway.
    Hu W; Hu Y; Pei Y; Li R; Xu F; Chi X; Mi J; Bergquist J; Lu L; Zhang L; Yang C
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
    Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
    J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
    Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
    Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
    Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
    J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTX3L is upregulated in glioma and is associated with glioma progression.
    Xu P; Tao X; Zhao C; Huang Q; Chang H; Ban N; Bei Y; Xia X; Shen C; Wang K; Xu L; Wu P; Ren J; Wang D
    Int J Mol Med; 2017 Aug; 40(2):491-498. PubMed ID: 28627634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of FOXM1 as a Potential New Target for Melanoma.
    Miyashita A; Fukushima S; Nakahara S; Yamashita J; Tokuzumi A; Aoi J; Ichihara A; Kanemaru H; Jinnin M; Ihn H
    PLoS One; 2015; 10(12):e0144241. PubMed ID: 26640950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma.
    Laugier F; Finet-Benyair A; André J; Rachakonda PS; Kumar R; Bensussan A; Dumaz N
    Oncotarget; 2015 Sep; 6(29):28120-31. PubMed ID: 26356562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
    Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
    J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the PI3K-AKT pathway in melanoma.
    Davies MA
    Cancer J; 2012; 18(2):142-7. PubMed ID: 22453015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling.
    Kaduwal S; Jeong WJ; Park JC; Lee KH; Lee YM; Jeon SH; Lim YB; Min do S; Choi KY
    Oncotarget; 2015 Oct; 6(32):33091-105. PubMed ID: 26384305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.
    Jiang CC; Lai F; Thorne RF; Yang F; Liu H; Hersey P; Zhang XD
    Clin Cancer Res; 2011 Feb; 17(4):721-30. PubMed ID: 21088259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
    Matsuoka H; Tsubaki M; Yamazoe Y; Ogaki M; Satou T; Itoh T; Kusunoki T; Nishida S
    Exp Cell Res; 2009 Jul; 315(12):2022-32. PubMed ID: 19393235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
    Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
    Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
    Park JH; Ryu JM; Han HJ
    J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.
    Sinnberg T; Lasithiotakis K; Niessner H; Schittek B; Flaherty KT; Kulms D; Maczey E; Campos M; Gogel J; Garbe C; Meier F
    J Invest Dermatol; 2009 Jun; 129(6):1500-15. PubMed ID: 19078992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
    Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
    Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.
    Oudart JB; Doué M; Vautrin A; Brassart B; Sellier C; Dupont-Deshorgue A; Monboisse JC; Maquart FX; Brassart-Pasco S; Ramont L
    Oncotarget; 2016 Jan; 7(2):1516-28. PubMed ID: 26621838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.